{
    "organizations": [],
    "uuid": "79a6399b2f74bc1a438cbeb5aee7cb405582d7aa",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-neovacs-announces-positive-data-re/brief-neovacs-announces-positive-data-review-from-last-idsmb-review-prior-to-final-results-of-phase-iib-clinical-trial-of-ifnalpha-kinoid-in-lupus-idUSFWN1Q3010",
    "ord_in_thread": 0,
    "title": "Neovacs Announces Positive Data Review From Last IDSMB Review Prior To Final Results Of Phase IIb Clinical Trial Of Ifnalpha Kinoid In Lupus",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 13 (Reuters) - Neovacs Sa:\n* REG-NEOVACS ANNOUNCES POSITIVE DATA REVIEW FROM LAST IDSMB REVIEW PRIOR TO FINAL RESULTS OF PHASE IIB CLINICAL TRIAL OF IFNALPHA KINOID IN LUPUS\n* NEOVACS SA - FINAL TRIAL RESULTS EXPECTED IN JUNE 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-13T14:24:00.000+02:00",
    "crawled": "2018-02-14T12:27:20.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "neovacs",
        "sa",
        "announces",
        "positive",
        "data",
        "review",
        "last",
        "idsmb",
        "review",
        "prior",
        "final",
        "result",
        "phase",
        "iib",
        "clinical",
        "trial",
        "ifnalpha",
        "kinoid",
        "lupus",
        "neovacs",
        "sa",
        "final",
        "trial",
        "result",
        "expected",
        "june",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}